MIR6128

Across TCGA pan-cancer cohorts, MIR6128 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR6128 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR6128 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6128 expression acts as an unfavorable survival marker.

KIRP, LUAD, and STAD are the cancer types where MIR6128 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	63	view →
LUAD	DFS	Tertile	All	0.036	0.768	<.001	45	view →
STAD	OS	Tertile	III,IV	0.152	0.502	.027	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MIR6128–KIRP (OS)

Open the KIRP breakdown →